Treatment with bioartificial liver improves lung injury in a swine model of partial hepatectomy and ischemia/reperfusion.
Arkadopoulos
Nikolaos
N
Second Department of Surgery, University of Athens, Athens, Greece.
Kalimeris
Konstantinos
K
Papalois
Apostolos
A
Nastos
Constantinos
C
Papoutsidakis
Nikolaos
N
Defterevos
George
G
Zarkadis
Ioannis K
IK
Mikrou
Aggeliki
A
Pafiti
Agatha
A
Andreadou
Ioanna
I
Kostopanagiotou
Georgia
G
Smyrniotis
Vassilios
V
D000818:Animals; D001794:Blood Pressure; D016207:Cytokines / Q000235:genetics; D004195:Disease Models, Animal; D019040:E-Selectin / Q000235:genetics; D006339:Heart Rate; D006498:Hepatectomy / Q000009:adverse effects*; D022781:Hepatocytes / Q000473:pathology; D019164:Liver, Artificial / Q000662:veterinary*; D008168:Lung / Q000473:pathology; D009336:Necrosis; D052247:Nitric Oxide Synthase Type II / Q000235:genetics; D012333:RNA, Messenger / Q000235:genetics; D015424:Reperfusion; D015427:Reperfusion Injury / Q000601:surgery*; D020133:Reverse Transcriptase Polymerase Chain Reaction; D050796:STAT3 Transcription Factor / Q000235:genetics; D013552:Swine; D013990:Tidal Volume; D016211:Transforming Growth Factor alpha / Q000235:genetics
D016207:Cytokines; D019040:E-Selectin; D012333:RNA, Messenger; D050796:STAT3 Transcription Factor; D016211:Transforming Growth Factor alpha; D052247:Nitric Oxide Synthase Type II